Name: hsBCL9CT-24
Rating: 5 (10 reviews)

有库存

sdf 文件

结构编辑

类似物检索

HIT ID:HIT218903927
Cas No:
常用名:hsBCL9CT-24
IUPAC:(2S)-N-[(1S,2R)-1-{[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-{[(1S)-1-carbamoyl-3-methylbutyl]carbamoyl}-1-methylhex-5-en-1-yl]carbamoyl}butyl]carbamoyl}-3-carbamoylpropyl]carbamoyl}-2-methylbutyl]carbamoyl}-1-methylhex-5-en-1-yl]carbamoyl}butyl]carbamoyl}-3-methylbutyl]carbamoyl}-2-hydroxypropyl]-2-[(2S)-2-acetamido-4-methylpentanamido]pentanediamide
IUPAC:(2S)-N-[(1S,2R)-1-{[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-{[(1S)-1-carbamoyl-3-methylbutyl]carbamoyl}-1-methylhex-5-en-1-yl]carbamoyl}butyl]carbamoyl}-3-carbamoylpropyl]carbamoyl}-2-methylbutyl]carbamoyl}-1-methylhex-5-en-1-yl]carbamoyl}butyl]carbamoyl}-3-methylbutyl]carbamoyl}-2-hydroxypropyl]-2-[(2S)-2-acetamido-4-methylpentanamido]pentanediamide
InChI key:AXCCVQFOUGCQED-GHHLTLIXSA-N

分子式:C68H122N20O15
分子量:1459.849
氢键供体数 (HBD):
氢键受体数 (HBA):
LogP:
SMILES:CC[C@H](C)[C@H](NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@](C)(CCCC=C)C(=O)N[C@@H](CC(C)C)C(N)=O
SMILES:CC[C@H](C)[C@H](NC(=O)[C@](C)(CCCC=C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@](C)(CCCC=C)C(=O)N[C@@H](CC(C)C)C(N)=O

hsBCL9CT-24 为Wnt/β-catenin(β-cat) 通路的抑制剂，展现出显著的抗肿瘤活性。该化合物能复苏因致癌Wnt通路所抑制的抗癌免疫反应，常被应用于癌症研究领域。

市场产品/服务共显示1个结果

您无法确定哪种化合物库最适合您的项目？或者您需要定制解决方案？Anymole随时为您提供帮助。

电话：400820-0310

合作：info@screeningcompound.com

技术支持：tech@screeningcompound.com

客服：service@screeningcompound.com

正在加载 ~